ClinicalTrials.gg
Drug

Roxadustat clinical trials

Also written FG-4592 and ASP1517.

studies test it
63
open now
6
in phase 3
26
first study started
2006

How each study uses roxadustat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the roxadustat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
18 Aug 2021 · Evrenzo · EMEA/H/C/004871 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Roxadustat
51
Evrenzo
5

Development codes

FG-4592
29
ASP1517
25
AZD9941
4

Studies by the year they started

62 studies that test it; most in 2016 (8); 1 more planned to start later

Studies that test roxadustat, by start year
YearStudies
20061
20091
20104
20113
20122
20136
20145
20153
20168
20172
20182
20193
20203
20216
20222
20233
20242
20255
20261

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
17
Phase 3
26
Phase 4
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 47 · Other 16

FibroGen (21) · Astellas Pharma Inc (13) · Astellas Pharma Europe B.V. (7) · AstraZeneca (3) · Astellas Pharma Global Development, Inc. (2) · Peking University First Hospital (2) · Mansoura University (2) · Peking Union Medical College Hospital (2)

Often tested with

Tested in the same studies.

Darbepoetin alfa (2) · Lanthanum carbonate (1) · AST 120 (1) · Charcoal (1) · Sacubitril valsartan (1) · Erythropoietin (1) · Tretinoin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 2 in phase 3

Studies that test roxadustat, phase 3 first.

Studies

Open first, then newest update. How each study uses roxadustat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 63

See all 63 studies that test roxadustat →

Given beside what is tested · 1 — roxadustat is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with roxadustat

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call roxadustat · ClinicalTrials.gg INT006377

  • MeSH (NLM) C584543roxadustatOne source NLM
  • UNII (FDA) X3O30D9YMXROXADUSTATConfirmed FDA, NLM, Wikidata
  • Wikidata Q27088611roxadustatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C141436RoxadustatOne source FDA
  • DrugBank DB04847One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.